ArticleJournal of clinical medicine2026
Novel Therapies, Residual Risk, Familial Hypercholesterolemia, and Digital Tools: Multispecialty Insights from a Dyslipidemia Management Survey.
António Mesquita-Lousada, Antónia Rocha-Melo-Sousa, Carolina Teixeira, Tiago Rodrigues Guimarães, Mário Marques-Vieira, José Paulo Andrade, Hugo Ribeiro, Manuel Neiva-Sousa, João Rocha-Neves
Abstract read
In one paragraphArticle in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
António Mesquita-LousadaFaculty of Medicine, University of Porto, Alameda Professor Hernâni Monteiro, 4200-319 Porto, Portugal.ORCID 0009-0006-8466-565X Antónia Rocha-Melo-SousaFaculty of Medicine, University of Porto, Alameda Professor Hernâni Monteiro, 4200-319 Porto, Portugal.
Carolina TeixeiraUnidade de Saúde Familiar-Barão do Corvo, Unidade Local de Saúde do Vila Nova de Gaia/Espinho, EPE, 4400-037 Vila Nova de Gaia, Portugal.
Tiago Rodrigues GuimarãesDepartment of Surgery, Unidade Local de Saúde do Barcelos Esposende, 4754-909 Barcelos, Portugal.ORCID 0009-0002-9948-7009 Mário Marques-VieiraDepartment of Angiology and Vascular Surgery, Unidade Local de Saúde de Braga, 4710-243 Braga, Portugal.ORCID 0000-0002-9908-9003 José Paulo AndradeRISE-Health, Department of Biomedicine, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.ORCID 0000-0003-2585-200X Hugo RibeiroMEDCIDS-Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Rua Dr. Plácido da Costa, 4200-450 Porto, Portugal.ORCID 0000-0001-6623-7420 Manuel Neiva-SousaFunctional Unit of Maxillofacial Surgery, Unidade Local de Saúde do Alto Ave (ULSAAVE), 4835-044 Guimarães, Portugal.ORCID 0000-0001-7674-3044 João Rocha-NevesRISE-Health, Department of Biomedicine, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.ORCID 0000-0002-2656-8935 Funding
Foundation for Science and Technology RISE-Health - UID/06397/2025
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
apolipoprotein Bcardiovascular risk assessmentdigital decision-supportfamilial hypercholesterolemiaLDL-Clipoprotein(a)PCSK9 inhibitors
Identifiers
PMID42279067
PMCPMC13258806
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390